Evidence map›Paper›PMID 30701970›Full record

ArticleChemical research in toxicology2019

Aromatic Residues at the Dimer-Dimer Interface in the Peroxiredoxin Tsa1 Facilitate Decamer Formation and Biological Function.

Matthew A Loberg, Jennifer E Hurtig, Aaron H Graff, Kristin M Allan, John A Buchan, Matthew K Spencer, Joseph E Kelly, Jill E Clodfelter, Kevin A Morano, W Todd Lowther and 1 more

Abstract read
In one paragraph

Article in Chemical research in toxicology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Real-time monitoring of peroxiredoxin oligomerization dynamics in living cells.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Matthew A LobergBiochemistry & Molecular Biology Program, Departments of Biology and Chemistry , The College of Wooster , Wooster , Ohio 44691 , United States.
Jennifer E HurtigBiochemistry & Molecular Biology Program, Departments of Biology and Chemistry , The College of Wooster , Wooster , Ohio 44691 , United States.
Aaron H GraffDepartment of Biochemistry and Center for Structural Biology , Wake Forest School of Medicine , Winston-Salem , North Carolina 27101 , United States.
Kristin M AllanBiochemistry & Molecular Biology Program, Departments of Biology and Chemistry , The College of Wooster , Wooster , Ohio 44691 , United States.
John A BuchanBiochemistry & Molecular Biology Program, Departments of Biology and Chemistry , The College of Wooster , Wooster , Ohio 44691 , United States.
Matthew K SpencerBiochemistry & Molecular Biology Program, Departments of Biology and Chemistry , The College of Wooster , Wooster , Ohio 44691 , United States.
Joseph E KellyBiochemistry & Molecular Biology Program, Departments of Biology and Chemistry , The College of Wooster , Wooster , Ohio 44691 , United States.
Jill E ClodfelterDepartment of Biochemistry and Center for Structural Biology , Wake Forest School of Medicine , Winston-Salem , North Carolina 27101 , United States.
Kevin A MoranoDepartment of Microbiology & Molecular Genetics, McGovern Medical School , The University of Texas Health Science Center at Houston , Houston , Texas 77030 , United States.
W Todd LowtherDepartment of Biochemistry and Center for Structural Biology , Wake Forest School of Medicine , Winston-Salem , North Carolina 27101 , United States.
James D WestBiochemistry & Molecular Biology Program, Departments of Biology and Chemistry , The College of Wooster , Wooster , Ohio 44691 , United States.ORCID 0000-0003-0892-5254
College of Wooster · USWake Forest University · USThe University of Texas Health Science Center at Houston · US

Funding

Tumor Tissue CoreP30CA012197 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Ruben A. Mesa · 1985 to 2026
$55.4M
Structures &Redox Chemistry in Sulfinic Acid ReductionR01GM072866 · NIGMS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI LOWTHER, W TODD · 2005 to 2014
$2.6M
Mechanisms of cytosolic proteostasis in yeastR01GM127287 · NIGMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MORANO, KEVIN ANTHONY · 2018 to 2021
$1.4M
NCI NIH HHS P30 CA012197NIGMS NIH HHS R01 GM072866NIGMS NIH HHS R01 GM127287
6 · The paper itself

Abstract

To prevent the accumulation of reactive oxygen species and limit associated damage to biological macromolecules, cells express a variety of oxidant-detoxifying enzymes, including peroxiredoxins. In Saccharomyces cerevisiae, the peroxiredoxin Tsa1 plays a key role in peroxide clearance and maintenance of genome stability. Five homodimers of Tsa1 can assemble into a toroid-shaped decamer, with the active sites in the enzyme being shared between individual dimers in the decamer. Here, we have examined whether two conserved aromatic residues at the decamer-building interface promote Tsa1 oligomerization, enzymatic activity, and biological function. When substituting either or both of these aromatic residues at the decamer-building interface with either alanine or leucine, we found that the Tsa1 decamer is destabilized, favoring dimeric species instead. These proteins exhibit varying abilities to rescue the phenotypes of oxidant sensitivity and genomic instability in yeast lacking Tsa1 and Tsa2, with the individual leucine substitutions at this interface partially complementing the deletion phenotypes. The ability of Tsa1 decamer interface variants to partially rescue peroxidase function in deletion strains is temperature-dependent and correlates with their relative rate of reactivity with hydrogen peroxide and their ability to interact with thioredoxin. Based on the combined results of in vitro and in vivo assays, our findings indicate that multiple steps in the catalytic cycle of Tsa1 may be impaired by introducing substitutions at its decamer-building interface, suggesting a multifaceted biological basis for its assembly into decamers.

Indexed as

DimerizationModels, MolecularPeroxidasesSaccharomyces cerevisiae ProteinsSoftwarePeroxidasesSaccharomyces cerevisiae ProteinsTsa1 protein, S cerevisiae

Identifiers

PMID30701970
PMCPMC7036284
OpenAlexW2911625607

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.